These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9835413)
1. In vivo and in vitro production of monoclonal antibodies: current possibilities and future perspectives. Introduction. de Geus B; Hendriksen CF Res Immunol; 1998; 149(6):533-4. PubMed ID: 9835413 [No Abstract] [Full Text] [Related]
2. In vivo and in vitro production of monoclonal antibodies: current possibilities and future perspectives. Discussion. Hendriksen CF; de Leeuw WA Res Immunol; 1998; 149(6):611-20. PubMed ID: 9835427 [No Abstract] [Full Text] [Related]
3. Considerations for in vitro monoclonal antibody production. Peterson NC Res Immunol; 1998; 149(6):553-7. PubMed ID: 9835417 [No Abstract] [Full Text] [Related]
4. Hollow fibre bioreactors: an alternative to murine ascites for small scale (<1 gram) monoclonal antibody production. Lipman NS; Jackson LR Res Immunol; 1998; 149(6):571-6. PubMed ID: 9835420 [No Abstract] [Full Text] [Related]
6. Membrane-based cell culture technologies: a scientifically and economically satisfactory alternative to malignant ascites production for monoclonal antibodies. Marx U Res Immunol; 1998; 149(6):557-9. PubMed ID: 9835418 [No Abstract] [Full Text] [Related]
7. In vivo and in vitro production of monoclonal antibodies. Bioreactors vs immune ascites. Marx U; Merz W Methods Mol Biol; 1995; 45():169-76. PubMed ID: 7550678 [No Abstract] [Full Text] [Related]
8. Production of monoclonal antibodies by the ascites method in laboratory animals. Hendriksen CF; de Leeuw W Res Immunol; 1998; 149(6):535-42. PubMed ID: 9835414 [No Abstract] [Full Text] [Related]
9. Production of monoclonal antibody supernatant and ascites fluid. Yokoyama WM Curr Protoc Mol Biol; 2001 May; Chapter 11():Unit11.10. PubMed ID: 18265068 [TBL] [Abstract][Full Text] [Related]
10. Production of monoclonal antibody supernatant and ascites fluid. Yokoyama WM Curr Protoc Mol Biol; 2008 Jul; Chapter 11():Unit 11.10. PubMed ID: 18633992 [TBL] [Abstract][Full Text] [Related]
11. Production of human monoclonal antibody in mouse ascites. Truitt KE; Larrick JW; Raubitschek AA; Buck DW; Jacobson SW Hybridoma; 1984; 3(2):195-9. PubMed ID: 6480025 [TBL] [Abstract][Full Text] [Related]
12. Production of monoclonal antibodies in the miniPERM bioreactor: comparison with other hybridoma culture methods. Falkenberg FW Res Immunol; 1998; 149(6):560-70. PubMed ID: 9835419 [No Abstract] [Full Text] [Related]
13. [Optimal production of murine monoclonal antibodies in ascites of syngeneic mice by a single whole body irradiation]. Witt S; Ziegler B; Klöting I; Nadrowitz R; Schmidt W; Ziegler M Allerg Immunol (Leipz); 1987; 33(4):259-64. PubMed ID: 2964179 [TBL] [Abstract][Full Text] [Related]
14. Methods of measuring antibodies in sera/plasma, ascites, and tissue-culture media. Rudbach JA; Cantrell JL; Ulrich JT Methods Mol Biol; 1995; 45():79-82. PubMed ID: 7550695 [No Abstract] [Full Text] [Related]
15. Methods for the production of xenogeneic monoclonal antibodies in murine ascites. Weissman D; Parker DJ; Rothstein TL; Marshak-Rothstein A J Immunol; 1985 Aug; 135(2):1001-3. PubMed ID: 4008923 [No Abstract] [Full Text] [Related]
16. Influence of priming and inoculation dose on the production of monoclonal antibodies in two age groups of BALB/c mice. De Deken R; Brandt J; Ceulemans F; Geerts S; Beudeker R Hybridoma; 1994 Feb; 13(1):53-7. PubMed ID: 8200659 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody production in murine ascites. II. Production characteristics. Jackson LR; Trudel LJ; Fox JG; Lipman NS Lab Anim Sci; 1999 Feb; 49(1):81-6. PubMed ID: 10090099 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of small to moderate scale in vitro monoclonal antibody production via the use of the i-MAb gas-permeable bag system. Lipski LA; Witzleb MP; Reddington GM; Reddington JJ Res Immunol; 1998; 149(6):547-52. PubMed ID: 9835416 [No Abstract] [Full Text] [Related]
19. Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology. Trebak M; Chong JM; Herlyn D; Speicher DW J Immunol Methods; 1999 Nov; 230(1-2):59-70. PubMed ID: 10594354 [TBL] [Abstract][Full Text] [Related]
20. The use of oxygen carriers for increasing the production of monoclonal antibodies from hollow fibre bioreactors. Shi Y; Sardonini CA; Goffe RA Res Immunol; 1998; 149(6):576-87. PubMed ID: 9835421 [No Abstract] [Full Text] [Related] [Next] [New Search]